Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology

J Alzheimers Dis. 2018;65(2):659-682. doi: 10.3233/JAD-180179.


Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.

Keywords: Alzheimer’s disease; non-demented with AD-like pathology; postsynaptic density proteome; synapse.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Electrophoresis, Gel, Two-Dimensional
  • Female
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Humans
  • Male
  • Mass Spectrometry
  • Post-Synaptic Density / metabolism*
  • Post-Synaptic Density / pathology
  • Proteome / metabolism*
  • Proteomics
  • Subcellular Fractions


  • Proteome